My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    1.

    Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.

    Triolo TM, Chase HP, Barker JM; DPT-1 Study Group.

    Diabetes Care. 2009 May;32(5):769-73.PMID: 19407074 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

    Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2008 Mar;31(3):528-33. Epub 2007 Nov 13.PMID: 18000175 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.

    Greenbaum CJ, Cuthbertson D, Krischer JP; Disease Prevention Trial of Type I Diabetes Study Group.

    Diabetes. 2001 Feb;50(2):470-6.PMID: 11272162 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

    Stene LC, Barriga K, Hoffman M, Kean J, Klingensmith G, Norris JM, Erlich HA, Eisenbarth GS, Rewers M.

    Pediatr Diabetes. 2006 Oct;7(5):247-53.PMID: 17054445 [PubMed - indexed for MEDLINE]Related articles

    5.

    Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.

    Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr.

    Acad Emerg Med. 2008 Dec;15(12):1241-7. Epub 2008 Sep 8.PMID: 18785943 [PubMed - indexed for MEDLINE]Related articles

    6.

    Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.

    Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN.

    Diabetes Care. 2007 May;30(5):1120-4. Epub 2007 Mar 2.PMID: 17337498 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.

    Mahon JL, Sosenko JM, Rafkin-Mervis L, Krause-Steinrauf H, Lachin JM, Thompson C, Bingley PJ, Bonifacio E, Palmer JP, Eisenbarth GS, Wolfsdorf J, Skyler JS; TrialNet Natural History Committee; Type 1 Diabetes TrialNet Study Group.

    Pediatr Diabetes. 2009 Apr;10(2):97-104. Epub 2008 Sep 24.PMID: 18823409 [PubMed - indexed for MEDLINE]Related articles

    8.

    Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.

    Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG.

    Diabetologia. 1998 May;41(5):536-41.PMID: 9628270 [PubMed - indexed for MEDLINE]Related articles

    9.

    Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.

    Lorini R, Alibrandi A, Vitali L, Klersy C, Martinetti M, Betterle C, d'Annunzio G, Bonifacio E; Pediatric Italian Study Group of Prediabetes.

    Diabetes Care. 2001 Jul;24(7):1210-6.PMID: 11423504 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Matheson D, Skyler JS.

    Diabetes Care. 2008 Nov;31(11):2188-92. Epub 2008 Jul 23.PMID: 18650369 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years.

    Wroblewski M, Gottsater A, Lindgarde F, Fernlund P, Sundkvist G.

    Diabetes Care. 1998 Feb;21(2):250-5.PMID: 9539991 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.

    Barker JM, McFann K, Harrison LC, Fourlanos S, Krischer J, Cuthbertson D, Chase HP, Eisenbarth GS; DPT-1 Study Group.

    J Pediatr. 2007 Jan;150(1):31-36.e6.PMID: 17188609 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.

    Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP; DPT-1 Participating Investigators.

    Diabetes. 2001 Aug;50(8):1735-40.PMID: 11473032 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

    Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

    Diabetes Care. 1998 Aug;21(8):1221-5.PMID: 9702423 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

    Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

    Metabolism. 2003 Jan;52(1):25-9.PMID: 12524658 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas]

    Wierusz-Wysocka B, Zozulińska D, Knast B, Pisarczyk-Wiza D.

    Pol Arch Med Wewn. 2001 Sep;106(3):815-21. Polish. PMID: 11928591 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.

    Adam JM, Tarigan NP.

    Acta Med Indones. 2004 Jan-Mar;36(1):3-7.PMID: 15931695 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.

    Freemark M, Bursey D.

    Pediatrics. 2001 Apr;107(4):E55.PMID: 11335776 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?

    Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She JX, Greenbaum C, Krischer J.

    Pediatr Diabetes. 2004 Jun;5(2):72-9.PMID: 15189492 [PubMed - indexed for MEDLINE]Related articles

    20.

    Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS.

    Diabetes Care. 2006 Mar;29(3):643-9.PMID: 16505520 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity